On-Demand Downstream Manufacturing Webinars

  1. Inside The Development Of An AAV8 Production Platform 4/24/2025

    Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.

  2. A Holistic Approach To Process Scale-Up 4/14/2025

    Explore an innovative concept that optimizes USP and DSP processes, as well as discover scale-up results and a fully automated and integrative DSP system.

  3. Optimize Your Process For Producing High-Concentration Drugs 4/10/2025

    Explore the challenges and solutions in high-concentration monoclonal antibody manufacturing, which includes practical strategies for maximizing product recovery and optimizing processes for efficient production.

  4. From 10 Days To 3: Transforming ADC Processes With Single-Use Tools 4/4/2025

    Learn how a collaborative partnership streamlined antibody-drug conjugate processes using a single-use, multi-step system to reduce operator time by 68%.

  5. Navigating Downstream Bioprocessing For Biosimilar Development 3/31/2025

    Unlock efficient biosimilar production with expert insights that reveal how advanced purification technologies can significantly reduce costs and meet stringent regulatory demands in today's market.

  6. Tools For Efficient Downstream Processing Of Antibody-Based Therapeutics 3/20/2025

    Watch and discover how to effectively utilize chromatography tools for improved purification of therapeutic monoclonal antibodies and antibody derivatives.

  7. Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective 2/18/2025

    Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.

  8. Scalable Expansion And Downstream Processing Of High-Quality hiPSCs 1/31/2025

    Learn about a scalable, microcarrier-based 3D culture process for expanding hiPSCs to 10L, yielding over 10 billion cells while maintaining quality.

  9. The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies 1/29/2025

    Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.

  10. mAb Up- And Downstream Process Intensification Strategies 12/12/2024

    Discover how to reduce monoclonal antibody (mAb) manufacturing time and costs through process intensification. Learn about continuous perfusion, ultrahigh cell density banks, and more.